Vistin Pharma ASA

kr 18.85As of Sun 8 Nov 2026, 12:00 UTC
OSL:VISTNHealthcare
Country Norway
PE (Fwd) •••
TSR 10Y CAGR 3.61%
Div yield 7.96%
ROE 19.46%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.58
PE TTM 13.35
TSR TTM (9.49%)
Mkt cap kr 835.9M
ROIC 17.68%
SE Grade™
Value
Quality
Moat
Consensus
Reference
kr 20
5.00%
59.25%
Hold 9|6|3|2|0
4Q25
1Q26
2Q26
3Q26
Earnings per sharekr
0.24
0.24
0.25
0.27
17.09%
10.35%
13.61%
16.50%
Revenuekr M
48.01
50.30
50.54
50.61
7.85%
7.35%
8.95%
8.88%
Peers (US$88.42M)
Cap (US$)
PE
127.2M
24.59x
Capital
TTM
5Y
10Y
Leveragex
4.539
0.201
0.163
EBIT/Intx
11.97
0.256
0.269
Own earn%
(70.67)
33.62
20.60
Sh yield%
56.16
25.89
25.79
Owners
Insiders/Inst%
6.98
40.00
Short interest%
2.46
SBC / revenue%
0.50
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
26–31
$1 testx
—
Incr. ROIC%
1